The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

BACKGROUND: CTLA-4 (Cytotoxic T lymphocyte antigen-4) is traditionally known as a negative regulator of T cell activation. The blocking of CTLA-4 using human monoclonal antibodies, such as Ipilimumab, is currently used to relieve CTLA-4-mediated inhibition of anti-tumor immune response in metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurent, Stefania, Queirolo, Paola, Boero, Silvia, Salvi, Sandra, Piccioli, Patrizia, Boccardo, Simona, Minghelli, Simona, Morabito, Anna, Fontana, Vincenzo, Pietra, Gabriella, Carrega, Paolo, Ferrari, Nicoletta, Tosetti, Francesca, Chang, Lung-Ji, Mingari, Maria Cristina, Ferlazzo, Guido, Poggi, Alessandro, Pistillo, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663700/
https://www.ncbi.nlm.nih.gov/pubmed/23634660
http://dx.doi.org/10.1186/1479-5876-11-108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663700/
https://www.ncbi.nlm.nih.gov/pubmed/23634660
http://dx.doi.org/10.1186/1479-5876-11-108

Ejemplares similares